Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07370493Enrolling By Invitation

Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices

Role: lead

NCT04012996Not ApplicableActive Not Recruiting

2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C

Role: lead

NCT05610397Unknown

Retrospective Study With Patients Treated With STALIF® C or M and Ti or FLX Implants for 1 and 2 Levels

Role: lead

All 3 trials loaded